Liver biopsy in inflammatory bowel disease patients with sustained abnormal liver function tests: a retrospective single-center study

• Type: Article in International Scientific Journal
• Date: 2023

Authors

Dias, E (Author) Other; Andrade, P (Author) Other; Lopes, S (Author) FMUP; Goncalves, R (Author) Other; Cardoso, P (Author) Other; Gaspar, R (Author) Other; Cardoso, H (Author) Other; Lopes, J (Author) Other; Carneiro F (Author) FMUP; Macedo G (Author) FMUP

Journal

The Journal is awaiting validation by the Administrative Services.

Title: ANNALS OF GASTROENTEROLOGY

Vol. 36

Pages: 54-60

ISSN: 1108-7471

Publisher: HELLENIC SOC GASTROENTEROLOGY

Indexing

ISI Web of Knowledge - 0 Citations

Scopus - 6 Citations

Other information

Authenticus ID: P-00X-KS5

DOI: 10.20524/aog.2023.0761

Abstract (EN): Background Inflammatory bowel disease (IBD) may be associated with a wide range of hepatobiliary manifestations. This study aimed to characterize the spectrum of hepatobiliary disorders in patients with IBD who underwent liver biopsy for sustained abnormal liver function tests (LFT). Method A retrospective study was performed of all patients with IBD who underwent liver biopsy between January 2010 and December 2020 for sustained abnormal LFT (at least 6-month duration). Results A total of 101 patients were included, mostly male (62.4%), with a mean age of 44.4 +/- 13.3 years. The most common IBD type was Crohn's disease (61.4%). Median time interval between abnormal LFT and biopsy was 14 (7-36) months. Abnormal LFT was predominantly hepatocellular in 40 patients (39.6%), cholestatic in 26 (25.7%) and mixed in 35 (34.7%). The most frequent diseases were nonalcoholic fatty liver disease (NAFLD) in 33 patients (32.7%), drug-induced liver disease (DILI) in 30 (29.7%), autoimmune hepatitis (AIH) in 13 (12.9%) and primary sclerosing cholangitis (PSC) in 13 (12.9%). Three patients had primary biliary cholangitis. Remarkably, 70 patients (69.3%) already had fibrosis by the time of liver biopsy and in 6 (5.9%) liver disease was already detected in the stage of cirrhosis. Conclusions Abnormal LFT in IBD patients had a wide range of etiologies and histology was often essential for reaching a correct diagnosis. NAFLD, DILI, AIH and PSC were the most common diagnoses and patients often presented in cirrhotic stage. Therefore, liver biopsy must be considered early in IBD patients with unexplained sustained abnormal LFT.

Language: English

Type (Professor's evaluation): Scientific

No. of pages: 7